HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Robert A.E. Dion Permission Requests Google Scholar Articles by Dion, R. A.E. PubMed Articles by Dion, R. A.E. Related Collections Valve disease Related Article

---

Original Articles: Adult Cardiac

Invited Commentary

Department of Cardiac Surgery, Ziekenhuis Oost-Limburg – Campus St. Jan, Schiepse Bos 6, Genk 3600, Belgium

(Email: robert.dion@zol.be).

The first 20% of the full text of this article appears below.

The authors [1] conclude that intrinsic mitral valve (MV) pathology is frequently observed in hypertrophic cardiomyopathy (HCM) and that durable repair is feasible in only approximately half of the patients. I would add that this is only done by experienced surgeons, indeed, as a prosthetic valve has no systolic anterior motion (SAM) of the mitral coaptation line, and the authors have not been able to demonstrate a difference in survival between repair and replacement.

Their analysis identified 6 nonmutually exclusive groups, but why is a "long-leaflets group" different from the degenerative and myxomatous ones? Also, I hardly distinguished . . . [Full Text of this Article]

Related Article

Mitral Valve Abnormalities in Hypertrophic Cardiomyopathy: Echocardiographic Features and Surgical Outcomes

Ryan K. Kaple, Ross T. Murphy, Linda M. DiPaola, Penny L. Houghtaling, Harry M. Lever, Bruce W. Lytle, Eugene H. Blackstone, and Nicholas G. Smedira
Ann. Thorac. Surg. 2008 85: 1527-1535. [Abstract] [Full Text] [PDF]